RH · Rh
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
Insider Sentiment Score
Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-07-10 | DEMILIO MARK S |
Director |
Sell↓
Filing footnotes — Common Stock (Indirect)
This transaction was executed in multiple trades ranging from $167.61 to $168.01. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. Includes 2,295 shares previously owned directly by Mark Demilio which were subsequently contributed to The Mark S. Demilio Revocable Trust. Held by The Mark S. Demilio Revocable Trust. |
Common Stock
(I)
|
1,309 |
| 2026-07-10 | DEMILIO MARK S |
Director |
Sell↓
Filing footnotes — Common Stock (Indirect)
Held by The Mark S. Demilio Revocable Trust. |
Common Stock
(I)
|
1,136 |
| 2026-07-08 | FRIEDMAN GARY G |
Director, CHAIRMAN & CEO, 10% Owner |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was executed in multiple trades ranging from $156.21 to $157.07. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. |
Common Stock
|
400 |
| 2026-07-08 | FRIEDMAN GARY G |
Director, CHAIRMAN & CEO, 10% Owner |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was executed in multiple trades ranging from $160.3450 to $160.5950. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. |
Common Stock
|
2,123 |
| 2026-07-08 | FRIEDMAN GARY G |
Director, CHAIRMAN & CEO, 10% Owner |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was executed in multiple trades ranging from $157.2650 to $158.25. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. |
Common Stock
|
5,399 |
| 2026-07-08 | FRIEDMAN GARY G |
Director, CHAIRMAN & CEO, 10% Owner |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was executed in multiple trades ranging from $158.2900 to $159.2850. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. |
Common Stock
|
6,833 |
| 2026-07-08 | FRIEDMAN GARY G |
Director, CHAIRMAN & CEO, 10% Owner |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was executed in multiple trades ranging from $155.19 to $156.16. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. |
Common Stock
|
3,216 |
| 2026-07-08 | FRIEDMAN GARY G |
Director, CHAIRMAN & CEO, 10% Owner |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was executed in multiple trades ranging from $154.17 to $155.13. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. |
Common Stock
|
5,897 |
| 2026-07-08 | FRIEDMAN GARY G |
Director, CHAIRMAN & CEO, 10% Owner |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was executed in multiple trades ranging from $159.29 to $160.2450. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. |
Common Stock
|
24,370 |
| 2026-07-07 | FRIEDMAN GARY G |
Director, CHAIRMAN & CEO, 10% Owner |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was executed in multiple trades ranging from $171.00 to $171.22. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. |
Common Stock
|
395 |
| 2026-07-07 | FRIEDMAN GARY G |
Director, CHAIRMAN & CEO, 10% Owner |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was executed in multiple trades ranging from $170.00 to $170.99. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. |
Common Stock
|
7,298 |
| 2026-07-06 | FRIEDMAN GARY G |
Director, CHAIRMAN & CEO, 10% Owner |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was executed in multiple trades ranging from $169.00 to $169.20. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. |
Common Stock
|
39,271 |
| 2026-07-06 | FRIEDMAN GARY G |
Director, CHAIRMAN & CEO, 10% Owner |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was executed in multiple trades ranging from $170.00 to $170.38. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. |
Common Stock
|
29,798 |
| 2026-06-29 | ALBERINI CARLOS |
Director |
Buy↑
Filing footnotes — Common Stock (Indirect)
This transaction was executed in multiple trades ranging from $157.99 to $158.93. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Held by the Carlos and Andrea Alberini Trust. Includes 20,802 shares previously owned directly by Mr. Alberini which were subsequently contributed to the Carlos and Andrea Alberini Trust. |
Common Stock
(I)
|
300 |
| 2026-06-29 | ALBERINI CARLOS |
Director |
Buy↑
Filing footnotes — Common Stock (Indirect)
This transaction was executed in multiple trades ranging from $160.05 to $161.04. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Held by the Carlos and Andrea Alberini Trust. |
Common Stock
(I)
|
5,502 |
| 2026-06-29 | ALBERINI CARLOS |
Director |
Buy↑
Filing footnotes — Common Stock (Indirect)
This transaction was executed in multiple trades ranging from $161.08 to $161.96. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Held by the Carlos and Andrea Alberini Trust. |
Common Stock
(I)
|
5,586 |
| 2026-06-18 | DEMILIO MARK S |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
This award of restricted stock will vest in full on the one-year anniversary of the date of grant. |
Common Stock
|
843 |
| 2026-06-18 | Mitic Kathleen C. |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
This award of restricted stock will vest in full on the one-year anniversary of the date of grant. |
Common Stock
|
843 |
| 2026-06-18 | Krane Hilary K |
EVP, CAO & General Counsel |
Award↑
Filing footnotes — Common Stock (Direct)
This award of restricted stock will vest in full on the one-year anniversary of the date of grant. |
Common Stock
|
843 |
| 2026-06-18 | Belling Keith |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
This award of restricted stock will vest in full on the one-year anniversary of the date of grant. |
Common Stock
|
843 |
| 2026-06-18 | Rowghani Ali |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
This award of restricted stock will vest in full on the one-year anniversary of the date of grant. |
Common Stock
|
843 |
| 2026-06-18 | ALBERINI CARLOS |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
This award of restricted stock will vest in full on the one-year anniversary of the date of grant. |
Common Stock
|
843 |
| 2026-06-18 | DEMILIO MARK S |
Director |
Sell↓
Filing footnotes — Common Stock (Indirect)
This transaction was executed in multiple trades ranging from $144.00 to $144.12. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. Held by The Mark S. Demilio Revocable Trust. |
Common Stock
(I)
|
3,102 |
| 2026-06-18 | SCHLESINGER LEONARD A |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
This award of restricted stock will vest in full on the one-year anniversary of the date of grant. |
Common Stock
|
843 |
| 2026-06-16 | DEMILIO MARK S |
Director |
Sell↓
Filing footnotes — Common Stock (Indirect)
Held by The Mark S. Demilio Revocable Trust. Includes 4,125 shares previously owned directly by Mark Demilio which were subsequently contributed to The Mark S. Demilio Revocable Trust. |
Common Stock
(I)
|
2,202 |
| 2026-04-14 | Chi Lisa |
Chief Merchandising Officer |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
This stock option award will vest and become exercisable over seven years as follows: 10% of the options will vest on each of the first, second and third anniversaries of the grant date, 15% of the options will vest on each of the fourth and fifth anniversaries of the grant date, and 20% of the options will vest on each of the sixth and seventh anniversaries of the grant date, subject to continuous service. |
Stock Option (Right to Buy)
|
30,000 |
| 2026-04-14 | Hargarten Christina |
CHIEF ACCOUNTING OFFICER |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
This stock option award will vest and become exercisable over seven years as follows: 10% of the options will vest on each of the first, second and third anniversaries of the grant date, 15% of the options will vest on each of the fourth and fifth anniversaries of the grant date, and 20% of the options will vest on each of the sixth and seventh anniversaries of the grant date, subject to continuous service. |
Stock Option (Right to Buy)
|
7,500 |
| 2026-04-14 | Preston Jack M |
CHIEF FINANCIAL OFFICER |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
This stock option award will vest and become exercisable over seven years as follows: 10% of the options will vest on each of the first, second and third anniversaries of the grant date, 15% of the options will vest on each of the fourth and fifth anniversaries of the grant date, and 20% of the options will vest on each of the sixth and seventh anniversaries of the grant date, subject to continuous service. |
Stock Option (Right to Buy)
|
25,000 |
| 2026-04-14 | DEMILIO MARK S |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The restricted stock award vests in eight equal quarterly installments over two years, subject to Mr. Demilio's continuing service on the Real Estate Committee of the Board of Directors, and shall be fully vested as of January 1, 2028. |
Common Stock
|
13,000 |
| 2026-04-14 | Chaya Eri |
Director, SEE REMARKS |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
This stock option award will vest and become exercisable over seven years as follows: 10% of the options will vest on each of the first, second and third anniversaries of the grant date, 15% of the options will vest on each of the fourth and fifth anniversaries of the grant date, and 20% of the options will vest on each of the sixth and seventh anniversaries of the grant date, subject to continuous service. |
Stock Option (Right to Buy)
|
40,000 |
| 2026-04-06 | Chaya Eri |
Director, SEE REMARKS |
Convert↑
Filing footnotes — Common Stock (Indirect)
Held by the Chaya-Smith Revocable Trust. The 25,000 shares acquired upon exercise of the stock option were acquired directly and subsequently transferred to the trust. |
Common Stock
(I)
|
25,000 |
| 2026-04-06 | Chaya Eri |
Director, SEE REMARKS |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
This option award is fully vested and exercisable. |
Stock Option (Right to Buy)
|
25,000 |
| 2026-03-31 | Chaya Eri |
Director, SEE REMARKS |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 7, 2024. This transaction was executed in multiple trades ranging from $136.65 to $137.57. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. |
Common Stock
|
1,600 |
| 2026-03-31 | Chaya Eri |
Director, SEE REMARKS |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 7, 2024. This transaction was executed in multiple trades ranging from $138.75 to $139.70. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. |
Common Stock
|
2,922 |
| 2026-03-31 | Chaya Eri |
Director, SEE REMARKS |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 7, 2024. This transaction was executed in multiple trades ranging from $137.72 to $138.68. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. |
Common Stock
|
1,678 |
| 2026-03-31 | Chaya Eri |
Director, SEE REMARKS |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 7, 2024. This transaction was executed in multiple trades ranging from $135.58 to $136.50. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. |
Common Stock
|
2,000 |
| 2026-03-31 | Chaya Eri |
Director, SEE REMARKS |
Convert↑
|
Common Stock
|
11,000 |
| 2026-03-31 | Chaya Eri |
Director, SEE REMARKS |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 7, 2024. This transaction was executed in multiple trades ranging from $139.75 to $140.64. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. |
Common Stock
|
1,700 |
| 2026-03-31 | Chaya Eri |
Director, SEE REMARKS |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 7, 2024. This transaction was executed in multiple trades ranging from $134.58 to $135.57. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. |
Common Stock
|
1,100 |
| 2026-03-31 | Chaya Eri |
Director, SEE REMARKS |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
This option award is fully vested and exercisable. |
Stock Option (Right to Buy)
|
11,000 |
| 2026-03-30 | Hargarten Christina |
CHIEF ACCOUNTING OFFICER |
Convert↑
Filing footnotes — Common Stock (Direct)
Each restricted stock unit represents a contingent right to receive one share of RH common stock. |
Common Stock
|
1,125 |
| 2026-03-30 | Hargarten Christina |
CHIEF ACCOUNTING OFFICER |
Convert↓
Filing footnotes — Restricted Stock Unit (RSU) (Direct)
Each restricted stock unit represents a contingent right to receive one share of RH common stock. On January 31, 2022, the reporting person was granted 7,500 restricted stock units. This restricted stock unit award vested with respect to 10% of the units on each of March 30, 2023, March 30, 2024 and March 30, 2025, 15% of the units vested on March 30, 2026, 15% of the units will vest on March 30, 2027, and 20% of the units will vest on each of March 30, 2028 and March 30, 2029, subject to continuous service. |
Restricted Stock Unit (RSU)
|
1,125 |
| 2026-03-24 | Chaya Eri |
Director, SEE REMARKS |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 7, 2024. This transaction was executed in multiple trades ranging from $130.38 to $131.19. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. |
Common Stock
|
1,518 |
| 2026-03-24 | Chaya Eri |
Director, SEE REMARKS |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 7, 2024. This transaction was executed in multiple trades ranging from $127.27 to $128.25. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. |
Common Stock
|
822 |
| 2026-03-24 | Chaya Eri |
Director, SEE REMARKS |
Convert↑
|
Common Stock
|
7,000 |
| 2026-03-24 | Chaya Eri |
Director, SEE REMARKS |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 7, 2024. This transaction was executed in multiple trades ranging from $129.30 to $130.28. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. |
Common Stock
|
2,177 |
| 2026-03-24 | Chaya Eri |
Director, SEE REMARKS |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
This option award is fully vested and exercisable. |
Stock Option (Right to Buy)
|
7,000 |
| 2026-03-24 | Chaya Eri |
Director, SEE REMARKS |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 7, 2024. This transaction was executed in multiple trades ranging from $128.29 to $129.21. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. |
Common Stock
|
2,483 |
| 2026-03-17 | Chaya Eri |
Director, SEE REMARKS |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
This option award is fully vested and exercisable. |
Stock Option (Right to Buy)
|
7,000 |
| 2026-03-17 | Chaya Eri |
Director, SEE REMARKS |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 7, 2024. This transaction was executed in multiple trades ranging from $136.15 to $136.74. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. |
Common Stock
|
1,008 |